Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 14 Anorexia 9 Endometrial Hyperplasia 7 Cachexia 7 Neoplasms 5 Breast Neoplasms 4 Overweight 2 Obesity 2 Body Weight Changes 2 Weight Loss 1 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Recurrence 1 Prosthesis Failure 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Nutrition Disorders 1 Neoplasms, Second Primary 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Exercise 10 Diet 6 Caloric Restriction 5 Metformin 4 Octreotide 3 Nutrition Assessment 3 Cognitive Behavioral Therapy 3 anamorelin 2 Standard of Care 2 Olanzapine 2 Mirtazapine 2 Melatonin 2 Liraglutide 2 Eicosapentaenoic Acid 2 Diet, Carbohydrate-Restricted 2 Diet Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 lime 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Urine Specimen Collection 1 Tirzepatide 1 TOPS 1 Surveys and Questionnaires 1 Sugars 1 Sampling Studies 1 Ritonavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Weight Loss × Megestrol Acetate × Clear all

NCT06998758 2025-12-12

MATRIX

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Recruiting

Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡